Study On Mechanism Risk Factors Of Pharmaceuticals Purchase By Public Bidding And Countermeasures

Object:Through knowing of current situation of Pharmaceuticals Purchase by Public Bidding,to analysis impaction on drug produce enterprises, drug sale enterprises, hospitals, and others affected stakeholders, then to identify risk factors on the mechanism of Pharmaceuticals Purchase by Public Bidding;to explore the risk factors and the feasibility of the measures focus on mechanism of Pharmaceuticals Purchase by Public Bidding, then to provide a theoretical basis and supporting data for the Government to further improve mechanism of Pharmaceuticals Purchase by Public Bidding.Methods:Principal component analysis: The purpose is through analysis of linear transformation, the original number of indicators form independent of each other a few can fully reflect the overall indicators of information, so as not to lose key information under the premise of avoiding a total of linear variable problems, For further analysis, the use of this method to focus on tendering mechanism drugs mining the deep-seated the key risk factors for the future development of effective mechanisms to reduce the risk of measures to targeted programmers.Cluster Analysis: It is all the categories of indicators n samples as different categories, and then the nature of the nearest (nearest) of the two merged into one category, and this n-1 category to find the nearest Two categories combined, and so on, until all the indicators / samples were merged into one category. The use of this method of principal components analysis of the results of further clustering, attributed to risk factors.On the basis of information analysis and the current Situation of Pharmaceuticals Purchase by Public Bidding in Wuhan city, the thesis will investigate risk factors against (drug produce enterprises, drug sale enterprises, hospitals). The thesis make a interview key insider interviews and focus group discussions against stakeholders',make use of macroeconomic policy analysis, SWOT, stakeholders'analysis, descriptive statistical methods for the quantitative and qualitative data analysis relating to mechanism of Pharmaceuticals Purchase by Public Bidding.Results:1.Basic information: The survey selects 6 of the Wuhan non-profit hospitals in good operation condition, the survey object including the procurement of drugs on the tender president, director of Pharmacy, Director of Finance, relevant departments in charge of clinical treatment and so on;Investigate 3 drugs produce enterprises that have adopt the GMP authentication,the targets include pharmaceutical production and the responsible persons, drug sales departments, departments of quality control, procurement of medicines on the tender departments, the Department of market development, sales and the Department of the Ministry of Finance and other relevant departments; Investigate 6 drugs sale enterprises in good condition and all through the GSP drugs certified enterprises,the targets include people responsible for the management of drugs, pharmaceuticals sales, procurement of the drugs on the tender, market development and the Department of the Ministry of Finance and other relevant departments in charge of personnel.In this study the subject of investigation for involvement or participation in the Pharmaceuticals Purchase by Public Bidding on the key insiders, and for its conduct focus group discussions and interviews.2.Through questionnaire survey and interview, to collect the information of the hospital on Pharmaceuticals Purchase by Public Bidding, including: the past three years revenues and expenditures of hospital drugs, hospital income of nearly three years, drugs of the total revenue ratio, and then to compare and analyze, The problems in the questionnaire to do a simple descriptive analysis, to explore risk factors of mechanism of Pharmaceuticals Purchase by Public Bidding.3.Through the questionnaire survey and interviews, do the descriptive analysis to the drugs produce enterprises and drugs sale enterprises, and do the testing to know whether there are differences view on the issue, and then to identify risk factors.4.Survey the basic information of Hospitals, drugs produce enterprises and drugs sale enterprises, on the basis of the survey and interviews information and through the principal component analysis and cluster analysis, attributed to risk factors of mechanism of Pharmaceuticals Purchase: the supervision of relevant government departments, focus on bidding and purchasing of drugs-related laws and policies, social environmental factors, drugs evaluation factors.5.Make use of Stakeholders analysis, establish all stakeholders relatively stable interest group model, the model based on the relevant interest groups focused on divided into four regions mechanism of Pharmaceuticals Purchase for the implementation of the tender will and the ability to be strong or weak ,establish all stakeholders relative movements of interest groups analysis model, the model based on the relevant interest groups focused on drugs procurement tender mechanism of the implementation of good strong or weak implementation capacity and poor ,it is also divided into four regions.6.SWOT analysis of in hospitals and drugs sale enterprises, which focus on the mechanism of Pharmaceuticals Purchase by Public Bidding, including, strengths, weaknesses, opportunities and threats.7.With regard to the procurement of drugs on the tender mechanism for the discussion of risk factors: and make the relevant policy proposals, To concentrate Pharmaceuticals Purchase by Public Bidding from the various stakeholders or risk key , and effectively avoid the risk factors to ensure that drugs on the bidding and purchasing mechanism for smooth functioning.Conclusions:1.Countermeasures for law of risk factors on mechanism of Pharmaceuticals Purchase by Public Bidding: the Government and relevant departments should actively use economic, legal, and administrative means, to concentrate on bidding and purchasing medicines and create a fair competitive environment to encourage pharmaceutical enterprises in technological innovation, to prevent low-level redundant construction and eliminate backward enterprises, and further improve the operation mechanism and supervision mechanism, medicine pricing mechanism, pharmaceutical production and the approval mechanism. 2.Countermeasures for the supervision of risk factors on mechanism of Pharmaceuticals Purchase by Public Bidding:relevant institutions (hospitals, drugs produce enterprises, drugs sale enterprises), as well as risk link (strict qualification access to the Commissioner, during the tender Supervision, bargaining session, after the supervision of the tender) to monitor; Speed up the innovation of health care system, straighten out the property rights mechanisms and compensation mechanism, improve the medical treatment technical specifications, establish of a doctor's prescription and evaluation system, and strengthen the supervision of a doctor's prescription;.Actively promote Chinese medicine circulation system, to break local protectionism and economic barriers, to implement a direct link between production and sales, to establish modern distribution systems and reduce intermediate links, finally, to change the current chaotic situation of drugs circulation system.3.Countermeasures for the evaluation of risk factors on mechanism of Pharmaceuticals Purchase by Public Bidding: a scientific evaluation system for drugs is important to Pharmaceuticals Purchase by Public Bidding,science, justice is the follow the principle of participation based on the evaluation system, the drugs evaluation system include:Drugs quality, price, credit, services and other factors.4. Countermeasures for the social environment of risk factors on mechanism of Pharmaceuticals Purchase by Public Bidding:Establish a social credit system and auxiliary of the corresponding disciplinary system, establish every link in drugs in circulation in the credit files of pharmaceutical production enterprises, distribution companies, hospitals and other retail terminals establish and improve the negative public records system on behalf of drug sellers, Doctors that related management of more employees, establish of adverse public records and disciplinary system.In a word,Actively make use of economic, legal, and administrative means, create an environment of fair competition for Pharmaceuticals Purchase by Public Bidding, Strengthen social supervision, strict new drugs approval and management, strengthen moral education, establish and improve credit system, actively promote the Reform, the Government should improve the medical institutions of compensation.